Ray Deshaies

Ray Deshais Dr. Deshaies is Professor and Executive Officer of Biology at the California Institute of Technology and an Investigator of the Howard Hughes Medical Institute. His career has focused on investigating the cellular machinery that mediates protein degradation by the ubiquitin-proteasome system (UPS), and how this machinery regulates cell division. Dr. Deshaies is a leading figure in the ubiquitin field and has published over 100 papers and is an inventor on nine issued U.S. patents, many related to his work on the UPS. For more about his work, visit his website. Dr. Deshaies has received numerous awards and scholarships, including Markey and Searle Scholar Awards and Burroughs-Wellcome and Beckman New Investigator Awards, in 1999 was selected as Young Investigator of the Year by the American Society for Cell Biology and in 2011 was elected to the American Academy of Arts and Sciences. In addition to being a co-founder of Cleave Biosciences (cleavebio.com), Dr. Deshaies was the academic co-founder of Proteolix, which was sold in October 2009 to Onyx in a deal valued at up to $851 million. He received a BS in Biochemistry from Cornell University, and his PhD in Biochemistry from the University of California, Berkeley.